| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 4 Feb 2025 | 25 Jan 2025 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve 1) Unaudited Financial Results along with Limited Review Report for the Quarter & Nine months ended December 31 2024; 2) Any other business with the permission of the Chair. Outcome of the Board Meeting held on 4th February, 2025 and has considered and approved Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2024. (As per BSE Announcement Dated on 04/02/2025) | ||
| Board Meeting | 11 Dec 2024 | 4 Dec 2024 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2024 inter alia to consider and approve 1) To Analyze and approve the request received for Reclassification of Shareholding from Promoter/Promoter Group to Public Category. 2) To appoint Dhawal Akhilesh Deopura (DIN: 09509762) as Additional Non-Executive Independent Director 2) Any other business with the permission of the Chair. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, we wish to inform that Board of Directors in their meeting held today i.e., 11/12/2024 has approved the agendas as listed in the Outcome of Board Meeting. We are submitting herewith Extract of the Minutes of the Board Meeting held today i.e., 11th December, 2024 at 04:00 P.M. at Registered Office of the Company. (As per BSE Announcement Dated on 11/12/2024) | ||
| Board Meeting | 13 Nov 2024 | 22 Oct 2024 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve We hereby inform you that Meeting of Board of Directors is scheduled to be held on Tuesday 29th October 2024 at 3:00 PM at Registered Office of the Company. Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve 1) To consider approval of Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2024. 2) Any other business with the permission of the Chairman. (As Per BSE Announcement Dated on: 26/11/2024) Outcome of Board Meeting to be held on Wednesday, 13th September, 2024 at Registered Office of the Company to discuss on agendas as per attached Outcome of Meeting. Results for Financial Results for Quarter and Half Year ended 30h September, 2024. (As per BSE Announcement Dated on 13/11/2024) | ||
| Board Meeting | 24 Aug 2024 | 16 Aug 2024 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2024 inter alia to consider and approve This is to inform that a Meeting of Board of Directors of the Company scheduled to be held on Saturday 24th August 2024 at Registered office of the Company to discuss AGM Related Agendas. Outcome of Board Meeting held on 24th August, 2024 and Disclosure under Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 (Listing Regulations) (As Per BSE Announcement dated on 24.08.2024) | ||
| Board Meeting | 15 Jul 2024 | 8 Jul 2024 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2024 inter alia to consider and approve This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 15th July 2024 at the Registered office of the Company to transact businesses as mentioned in the Intimation of Board Meeting. Outcome of the Board Meeting held on 15.07.2024 for Unaudited Financial Results for the quarter ended 30th June, 2024 (As Per BSE Announcement dated on 15.07.2024) | ||
| Board Meeting | 23 May 2024 | 14 May 2024 |
| Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve To consider approval of Audited FInancial Results for the Quarter and Year ended March 2024 Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, May 23, 2024 at Registered Office of the Company situated at 403, Sarthik II, Opp. Rajpath Club, S.G. Highway, Bodakdev, Ahmedabad- 380054, Gujarat, India, has inter alia considered and approved Audited Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended on 31st March, 2024 Pursuant to Regulation 30 and 33 of SEBI(LODR) Regulation, 2015, Board has approved Financial Results for Quarter and Year ended March, 2024. (As per BSE Announcement Dated on 23/05/2024) Clarification Letter for clerical and typographical error in the Annexure A (Financial Results filed for Quarter Ended 31st March, 2024). Disclosure under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that that we hereby rectified the following discrepancies: 1) EPS figures in Financial Results for the Quarter and Financial Year ended on 31st March, 2024; 2) Declaration regarding Audit report with unmodified opinion with respect to Annual Audited Financial Results for the Financial Year ended 31st March, 2024 (Annexure- B). (As Per BSE Announcement Dated on 25.06.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
